Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma

Respiratory Medicine

Volumn 100, Issue 9, 2006, Pages 1534-1539

  van Veen, Ilonka H ^a   ten Brinke, A ^b   van der Linden, A C ^a   Rabe, K F ^a   Bel, E H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Alpha 1 antitrypsin; Persistent airflow limitation; Phenotype; Severe asthma

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIBIOTIC AGENT; BECLOMETASONE; BRONCHODILATING AGENT; CORTICOSTEROID; PREDNISONE;

ADULT; AGED; AIRWAY OBSTRUCTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HETEROZYGOSITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; TOTAL LUNG CAPACITY; VITAL CAPACITY;

ADOLESCENT; ADULT; AGED; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PHENOTYPE; RISK FACTORS; VITAL CAPACITY;

EID: 33746192129     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.01.009     Document Type: Article

References (28)

1. ten Brinke A., Zwinderman A.H., Sterk P.J., Rabe K.F., and Bel E.H. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 164 5 (2001) 744-748
2. Lange P., Ulrik C.S., and Vestbo J. Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet 347 9011 (1996) 1285-1289
3. Hansen E.F., Phanareth K., Laursen L.C., Kok-Jensen A., and Dirksen A. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159 (1999) 1267-1271
4. Lange P., Parner J., Vestbo J., Schnohr P., and Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 339 (1998) 1194-1200
5. Miranda C., Busacker A., Balzar S., Trudeau J., and Wenzel S.E. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 113 1 (2004) 101-108
6. Burrows B., Lebowitz M.D., Barbee R.A., and Cline M.G. Findings before diagnoses of asthma among the elderly in a longitudinal study of a general population sample. J Allergy Clin Immunol 88 (1991) 870-877
7. Ulrik C.S., and Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 150 (1994) 629-634
8. Grol M.H., Gerritsen J., Vonk J.M., et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am J Respir Crit Care Med 160 (1999) 1830-1837
9. Peat J.K., Woolcock A.J., and Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 70 (1987) 171-179
10. Frette C., Annesi I., Korobaeff M., Neukirch F., Dore M.F., and Kauffmann F. Blood eosinophilia and FEV1. Cross-sectional and longitudinal analyses. Am Rev Respir Dis 143 (1991) 987-992
11. Ulrik C.S. Eosinophils and pulmonary function: an epidemiologic study of adolescents and young adults. Ann Allergy Asthma Immunol 80 (1998) 487-493
12. Carrell R.W., and Lomas D.A. Alpha1-antitrypsin deficiency-a model for conformational diseases. N Engl J Med 346 1 (2002) 45-53
13. Lomas D.A., and Parfrey H. Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology. Thorax 59 6 (2004) 529-535
14. Needham M., and Stockley R.A. Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax 59 5 (2004) 441-445
15. Sandford A.J., Chagani T., Weir T.D., Connett J.E., Anthonisen N.R., and Pare P.D. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 163 2 (2001) 469-473
16. Sigsgaard T., Brandslund I., Omland O., et al. S and Z alpha1-antitrypsin alleles are risk factors for bronchial hyperresponsiveness in young farmers: an example of gene/environment interaction. Eur Respir J 16 1 (2000) 50-55
17. Townley R.G., Southard J.G., Radford P., Hopp R.J., Bewtra A.K., and Ford L. Association of MS Pi phenotype with airway hyperresponsiveness. Chest 98 (1990) 594-599
18. Eden E., Mitchell D., Mehlman B., et al. Atopy, asthma, and emphysema in patients with severe alpha-1-antitrypysin deficiency. Am J Respir Crit Care Med 156 (1997) 68-74
19. Eden E., Hammel J., Rouhani F.N., et al. Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest 123 3 (2003) 765-771
20. Piitulainen E., and Sveger T. Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ). Thorax 57 8 (2002) 705-708
21. Quanjer P.H., Tammeling G.J., Cotes J.E., et al. Symbols, abbreviations and units. Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir J Suppl 16 (1993) 85-100
22. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., and Yernault J.C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16 (1993) 5-40
23. ten Brinke A., van Dissel J.T., Sterk P.J., Zwinderman A.H., Rabe K.F., and Bel E.H. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol 107 3 (2001) 449-454
24. Silva G.E., Sherrill D.L., Guerra S., and Barbee R.A. A longitudinal study of alpha1-antitrypsin phenotypes and decline in FEV1 in a community population. Chest 123 5 (2003) 1435-1440
25. von Ehrenstein O.S., Maier E.M., Weiland S.K., et al. Alpha1 antitrypsin and the prevalence and severity of asthma. Arch Dis Child 89 3 (2004) 230-231
26. de Serres F.J. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 122 5 (2002) 1818-1829
27. Miravitlles M., Vila S., Torrella M., et al. Influence of deficient alpha1-anti-trypsin phenotypes on clinical characteristics and severity of asthma in adults. Respir Med 96 3 (2002) 186-192
28. Vignola A.M., Bonanno A., Profita M., et al. Effect of age and asthma duration upon elastase and alpha1-antitrypsin levels in adult asthmatics. Eur Respir J 22 5 (2003) 795-801